Tevogen Bio Holdings (TVGN) Total Current Liabilities (2021 - 2026)

Tevogen Bio Holdings has reported Total Current Liabilities for 6 years, with the latest figure at $7.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 16.64% year-over-year to $7.3 million; the trailing twelve-month figure through Mar 2026 stood at $7.3 million (down 16.64% YoY), and the FY2025 full-year result was $7.1 million, down 21.83% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $7.3 million, up from $7.1 million in the prior quarter.
• The five-year high for Total Current Liabilities was $85.5 million in Q4 2023, with the low at $178999.0 in Q1 2022.
• Historically, Total Current Liabilities has averaged $9.8 million across 5 years, with a median of $7.1 million in 2025.
• Annual changes were most pronounced in 2023 — Total Current Liabilities surged 24291.09% — and 2024, when it tumbled 89.42%.
• Tevogen Bio Holdings' Total Current Liabilities stood at $350454.0 in 2022, then surged by 24291.09% to $85.5 million in 2023, then plunged by 89.42% to $9.0 million in 2024, then retreated by 21.83% to $7.1 million in 2025, then increased by 2.83% to $7.3 million in 2026.
• The last three Total Current Liabilities figures came in at $7.3 million (Q1 2026), $7.1 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.